← Leaderboards
Michael Thomas Marrone
Johns Hopkins University
$932,936
Attributed
$932,936
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $249K · FY2020–25$250K$187.5K$125K$62.5K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$932,936 · 2
By mechanism
R00$723,167 · 1
K99$209,769 · 1
Top collaborators
No co-investigators on record.
Most similar at Johns Hopkins University
Same institution · by research overlap
- Kenneth J. Pienta$43,861,680
- William George Nelson$34,555,726
- Martin G Pomper$38,517,075
- Shawn Lupold$4,097,268
- Angelo Michael De Marzo$8,441,808
Others in their field
Other Emerging Leaders on “Density”
- Eric C Palm · Florida State University$26,502,247
- Ross D McDonald · Florida State University$26,502,247
- Michael W Rabin · Florida State University$26,502,247
- Wally Narajowski$21,300,000
- Shadi Dayeh · University Of California, San Diego$13,862,272
- James Dale Berry · Brigham And Women'S Hospital$9,673,541
Research focus
DensityCytoplasmCollaborationsControlled EnvironmentCohortAreaAdvanced Prostate CancerBiologicalBiologyAnti-Tumor Immune ResponseCancer BiomarkersAdjuvantCancer ControlCancer EpidemiologyCareerCd8b1 GeneCell PhysiologyCellsCessation Of LifeCharacteristicsChemopreventive AgentBiomarker ValidationClinical Trials DesignDiagnosis
Grant awards (6)
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$222,658
R00 · FY2025 · CA · contact PI
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$26,341
R00 · FY2024 · CA · contact PI
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$225,168
R00 · FY2023 · CA · contact PI
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$249,000
R00 · FY2022 · CA · contact PI
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$104,810
K99 · FY2021 · CA · contact PI
Treg functional changes: a novel immune regulatory effect underlying the benefit of statin drug use on lethal prostate cancer$104,959
K99 · FY2020 · CA · contact PI